Approved medicines in Montenegro — L — Antineoplastic and immunomodulating agents (470)
- TRUQAPcapivasertibRxFilm-coated tablet, 160mgAstraZeneca AB, Sweden
- TRUQAPcapivasertibRxFilm-coated tablet, 200mgAstraZeneca AB, Sweden
- TYSABRInatalizumabRxConcentrate for solution for infusion, 300mg/15mlBiogen Netherlands B.V., Netherlands
- TYSABRInatalizumabRxSolution for injection in pre-filled syringe, 150mgBiogen Netherlands B.V., Netherlands
- TYVERBlapatinibRxFilm-coated tablet, 250mgGlaxo Wellcome Operations, United Kingdom
- ULTOMIRISravulizumabRxConcentrate for solution for infusion, 1100mg/11mlAlexion Pharma International Operations Limited, Ireland
- ULTOMIRISravulizumabRxConcentrate for solution for infusion, 300mg/3mlAlexion Pharma International Operations Limited, Ireland
- VECTIBIXpanitumumabRxConcentrate for solution for infusion, 20mg/mlAmgen Europe B.V., Netherlands
- VIDAZAazacitidineRxPowder for suspension for injection, 100mgBaxter Oncology GmbH, Germany
- VORTEMYELbortezomibRxPowder for solution for injection, 3.5mgSynthon Hispania S.L., Spain
- VOTRIENTpazopanibRxFilm-coated tablet, 400mgGlaxo Wellcome S.A., Spain
- VOTRIENTpazopanibRxFilm-coated tablet, 200mgGlaxo Wellcome S.A., Spain
- VOYDEYAdanicopanRxFilm-coated tablet, 100mgAlexion Pharma International Operations Limited, Ireland
- VOYDEYAdanicopanRxFilm-coated tablet, 50mg i 100mgAlexion Pharma International Operations Limited, Ireland
- XALKORIcrizotinibRxCapsule, hard, 200mgPfizer Manufacturing Deutschland GmbH, Germany
- XALKORIcrizotinibRxCapsule, hard, 250mgPfizer Manufacturing Deutschland GmbH, Germany
- XALVOBINcapecitabineRestrictedFilm-coated tablet, 500mgRemedica Ltd., Cyprus
- XELJANZtofacitinibRxFilm-coated tablet, 10mgPfizer Manufacturing Deutschland GmbH, Germany
- XELJANZtofacitinibRxFilm-coated tablet, 5mgPfizer Manufacturing Deutschland GmbH, Germany
- XELJANZtofacitinibRxProlonged-release tablet, 11mgPfizer Manufacturing Deutschland GmbH, Germany